Skip to main content

Table 1 Characteristics of eligible patients

From: Successful adjuvant bi-weekly gemcitabine chemotherapy for pancreatic cancer without impairing patients’ quality of life

 

Group A (n= 58)

 

Group B (n= 36)

 

P value

 

Number

%

Number

%

 

Age (years)

     

  Median

68

 

69.5

 

0.07

  Range

34–82

 

50–84

  

Sex

     

  Male

36

62.1

20

55.6

0.32

  Female

22

37.9

16

44.4

 

Operative procedure

     

  PDa

45

77.6

26

72.2

0.36

  DPb

13

22.4

10

27.8

 

Primary tumor size

     

  T1

3

5.2

1

2.8

 

  T2

8

13.8

8

22.2

0.47

  T3

36

62.1

21

58.3

 

  T4

11

19.0

6

16.7

 

Nodal status

     

  N0

27

46.6

15

41.7

0.45

  N1

31

53.4

21

58.3

 

Resection status c

     

  R0

38

65.5

22

61.1

0.49

  R1

20

34.5

14

38.9

 

UICC stage d

     

  I

10

17.2

7

19.4

 

  II

27

46.6

15

41.7

0.38

  III

7

12.1

4

11.1

 

  IV

14

24.1

10

27.8

 

Histology

     

  Adenocarcinoma

54

93.1

33

91.7

0.69

  Other

4

6.9

3

8.3

 
  1. a Pancreatoduodenectomy, b distal pancreatectomy, c R0 or R1 means negative or positive margin microscopically, d sixth edition of International Union Against Cancer stages.
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us